Evidence map›Paper›PMID 33088629›Full record

ArticlePeerJ2020

Hau V Doan, Pishyaporn Sritangos, Roongtip Iyara, Nuannoi Chudapongse

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Effect ofNutrients · 2024
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Hau V Doan *Department of Pharmacy, School of Medicine and Pharmacy, Tra Vinh University, Tra Vinh, Vietnam.
Pishyaporn SritangosSchool of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Muang, Nakhon Ratchasima, Thailand.
Roongtip IyaraSchool of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Muang, Nakhon Ratchasima, Thailand.
Nuannoi Chudapongse *School of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Muang, Nakhon Ratchasima, Thailand.
Suranaree University of Technology · THTra Vinh University · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma is the most common type of primary liver cancer in humans. This study aimed to demonstrate anticancer properties of an aqueous extract from

Indexed as

ApoptosisCell cyclesChrysophyllum cainitoHepatocellular carcinomaHepG2 cellReactive oxygen species

Identifiers

PMID33088629
PMCPMC7571409
OpenAlexW3092783590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.